Auris Medical Holding AG (EARS):企業の財務・戦略的SWOT分析

GlobalDataが発行した調査報告書(DATA904C5334)
◆英語タイトル:Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5334
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年9月
◆ページ数:44
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Auris Medical Holding AG (EARS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Auris Medical Holding AG (Auris Medical) is a clinical-stage biopharmaceutical company that develops therapeutics to address unmet medical needs in the area of otolaryngology. The company’s pipeline encompasses investigational candidates targeted at the treatment of acute inner ear tinnitus, post-acute inner ear tinnitus, tinnitus, sudden loss of hearing, and Meniere’s disease (Vertigo). Auris Medical also carries out research to advance various early-stage development projects in the area of rhinology. It works in collaboration with various research and development institutions and pharmaceutical and biotechnology companies. Auris Medical is headquartered in Zug, Switzerland.

Auris Medical Holding AG Key Recent Developments

Aug 15,2018: Auris Medical announces second quarter 2018 financial results
Jul 12,2018: Auris Medical Prices $7 Million Public Offering
May 15,2018: Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results
Apr 09,2018: Auris Medical Announces Early Repayment of Part of its Loan Facility
Mar 22,2018: Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Auris Medical Holding AG – Key Facts 5
Auris Medical Holding AG – Key Employees 6
Auris Medical Holding AG – Key Employee Biographies 7
Auris Medical Holding AG – Major Products and Services 8
Auris Medical Holding AG – History 9
Auris Medical Holding AG – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Auris Medical Holding AG – Business Description 12
R&D Overview 12
Auris Medical Holding AG – SWOT Analysis 13
SWOT Analysis – Overview 13
Auris Medical Holding AG – Strengths 13
Auris Medical Holding AG – Weaknesses 14
Auris Medical Holding AG – Opportunities 15
Auris Medical Holding AG – Threats 16
Auris Medical Holding AG – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 21
Financial Performance 21
Financial Ratios – Interim Ratios 22
Financial Ratios – Ratio Charts 23
Section 4 – Company’s Lifesciences Financial Deals and Alliances 24
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25
Auris Medical Holding AG, Recent Deals Summary 26
Section 5 – Company’s Recent Developments 27
Jul 12, 2018: Auris Medical Prices $7 Million Public Offering 27
May 15, 2018: Auris Medical Provides Business and Strategy Update and Reports First Quarter 2018 Financial Results 28
Apr 09, 2018: Auris Medical Announces Early Repayment of Part of its Loan Facility 30
Mar 22, 2018: Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results 31
Mar 16, 2018: Auris’ tinnitus treatment fails late-stage study for the second time 32
Dec 28, 2017: Auris Medical to Provide Update on Its AM-111 Hearing Loss Program on Thursday, January 4, 2018 33
Nov 28, 2017: Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update 34
Sep 26, 2017: Auris Medical Provides Board of Directors Update 36
Aug 10, 2017: Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results 37
May 31, 2017: Auris Medical to Host Key Opinion Leader Event Focused on Clinical-Stage Pipeline on June 16 in New York City 39
Section 6 – Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Auris Medical Holding AG, Key Facts 5
Auris Medical Holding AG, Key Employees 6
Auris Medical Holding AG, Key Employee Biographies 7
Auris Medical Holding AG, Major Products and Services 8
Auris Medical Holding AG, History 9
Auris Medical Holding AG, Subsidiaries 10
Auris Medical Holding AG, Key Competitors 17
Auris Medical Holding AG, Ratios based on current share price 18
Auris Medical Holding AG, Annual Ratios 19
Auris Medical Holding AG, Annual Ratios (Cont...1) 20
Auris Medical Holding AG, Interim Ratios 22
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25
Auris Medical Holding AG, Recent Deals Summary 26
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43

List of Figures
Auris Medical Holding AG, Performance Chart (2013 - 2017) 21
Auris Medical Holding AG, Ratio Charts 23
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Auris Medical Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 25

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Auris Medical Holding AG (EARS):企業の財務・戦略的SWOT分析(Auris Medical Holding AG (EARS) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆